#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor IX deficiency Hypersensitivity pneumonitis Neuroendocrine carcinoma metastatic Retinoblastoma Prolymphocytic leukaemia CDKL5 deficiency disorder Dent's disease Malignant neoplasm of choroid Postprandial hypoglycaemia Heart disease congenital Hepatocellular carcinoma Netherton's syndrome Osteogenesis imperfecta Blood iron increased Hypoparathyroidism More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma – Diagnostics Congenital nephrogenic diabetes insipidus – Diagnostics Retinitis pigmentosa – Diagnostics Pemphigus – Trials in Disease Myxofibrosarcoma – Life with Disease Chordoma – Diagnostics Primary immunodeficiency syndrome – Treatment Myelodysplastic syndrome – Life with Disease Short-bowel syndrome Marginal zone lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lamivudine Dapirolizumab Pegol Upadacitinib Larotrectinib Sulfate Micronised Spironolactone Avb-101 Guanabenz Acetate Naporafenib Dronabinol LY3841136 SODIUM Pazopanib Etripamil Etifoxine Hydrochloride Belatacept Codeine Phosphate Atuliflapon Gefitinib Fenfluramine Hydrochloride Dexpanthenol Noradrenaline Tartrate More therapies…

    Learn about Your Condition

    Radiation skin injury Partial seizures Intellectual disability Myotonic dystrophy Atrial septal defect Toxic epidermal necrolysis Aortic disorder Follicular lymphoma stage II Peritoneal sarcoma Anal cancer Renal disorder Von Willebrand's disease Chondropathy Cancer pain Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ospedale Vito Fazzi Lecce

Ospedale Vito Fazzi Lecce

Pdwpeh Fwqnpyn Mnznxqbx 1n Ltutdy 7pulfk Ixhnj

Want to learn more about this study or check if you can participate? Contact us.

  • Study of levofloxacin, ketorolac trometamol, and dexamethasone eye drops for preventing inflammation and infection after cataract surgery in adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone
    • KETOROLAC TROMETAMOL
    • Levofloxacin
    Greece Italy Poland Spain Sweden

  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • LY4170156
    • Bevacizumab
    • Carboplatin
    Austria Belgium Czechia Denmark France Germany +9

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Czechia France Germany Greece +4

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Mercaptopurine
    • Doxorubicin
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • AB521
    • Cabozantinib
    • Placebo
    Czechia France Germany Hungary Italy The Netherlands +3

  • Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Cetuximab
    • Bevacizumab
    Italy Spain

  • Study of Lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lisaftoclax
    • Azacitidine
    Italy Poland Spain

  • Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma

    Recruiting

    3 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Austria France Germany Italy Poland Spain
1 2 3 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!